Company History and Background
Apogenics was formed in 2006 in response to a customer request for real-world healthcare market insights. Collectively, the founders had decades of experience commercializing specialty pharmaceutical and biotechnology products and were asked to advise a manufacturer for a new product launch. Since that initial project, Apogenics has advised over 100 pharmaceutical, biotech, and healthcare services organizations throughout the world.
Apogenics advisory model provides manufacturers, health plans, pharmacy benefit managers (PBMs), specialty pharmacies and distributors, and clinical laboratories and healthcare providers with executive level management advisory services related to commercial strategy, customer research, operational excellence, market and operational analytics, risk and regulatory compliance, and financial services.
When considering patient service providers (HUBS), our team has led the market in the design and build-out, operational management, and subsequent audit analysis of all major HUB vendors in the marketplace, including manufacturer in-house HUB models. This broad experience benefits our clients as we work with both the manufacturers as well as their HUB and channel partners in developing and implementing launch strategies and measuring their value.
Predictive Modeling and Analysis
Apogenics offers its clients the ability to benchmark market access programs using its m2Msm platform. This platform, built on industry standard analytics software, allows our clients an unprecedented view of both provider and vendor operations. m2Msm brings managers the ability to measure and manage business processes — gaining a better understanding of barriers that affect access to their products.. Linked to Apogenics advisory services, m2Msm provides a highly sophisticated predicative algorithm that generates leading indicators, that help grow the business vs. the typical analysis of what happened, we find what is going to happen. m2Msm equips managers with the ability to plan, forecast, and address access barriers proactively – before they happen.
Government Programs and 340B Program Services
The Apogenics team is dedicated to providing 340B Program Services to hospitals and health systems with a focus on providing comprehensive and independent 340B HRSA Audits and Compliance Programs. Our team of experts has 20+ years of experience serving the 340B Community and has been involved with implementing and managing one of the first Hemophilia Treatment Center (340B) programs in the Country.